{"id":"https://openalex.org/W2005268147","doi":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","title":"Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease","display_name":"Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease","publication_year":1982,"publication_date":"1982-10-01","ids":{"openalex":"https://openalex.org/W2005268147","doi":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","mag":"2005268147","pmid":"https://pubmed.ncbi.nlm.nih.gov/6812613"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.1982.tb03888.x","doi":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005268147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029562668","display_name":"Edward G. D. Tuddenham","orcid":"https://orcid.org/0000-0001-8955-2909","observed_orcids":["https://orcid.org/0000-0001-8955-2909"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"E. G. D. Tuddenham","raw_affiliation_strings":["The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London","institution_ids":["https://openalex.org/I2801138448"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111733476","display_name":"R. S. Lane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. S. Lane","raw_affiliation_strings":["Blood Products Laboratory, Elstree, Herts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood Products Laboratory, Elstree, Herts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057648168","display_name":"Frances Rotblat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. Rotblat","raw_affiliation_strings":["The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London","institution_ids":["https://openalex.org/I2801138448"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055547526","display_name":"Alison J. Johnson","orcid":"https://orcid.org/0000-0002-8757-8053","observed_orcids":["https://orcid.org/0000-0002-8757-8053"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. J. Johnson","raw_affiliation_strings":["Department of Medicine, New York University Medical Centre, New York, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, New York University Medical Centre, New York, U.S.A","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. J. Snape","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T. J. Snape","raw_affiliation_strings":["Plasma Fractionation Laboratory, Churchill Hospital, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Plasma Fractionation Laboratory, Churchill Hospital, Oxford","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058127236","display_name":"Sarah M. Middleton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800962074","display_name":"Nottingham City Council","ror":"https://ror.org/0173xeq43","country_code":"GB","type":"government","lineage":["https://openalex.org/I2800962074"]},{"id":"https://openalex.org/I4210144187","display_name":"Nottingham Contemporary","ror":"https://ror.org/04dx63c61","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210144187"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Middleton","raw_affiliation_strings":["Speywood Laboratories Ltd, Bingham, Nottingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Speywood Laboratories Ltd, Bingham, Nottingham","institution_ids":["https://openalex.org/I2800962074","https://openalex.org/I4210144187"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110104812","display_name":"Peter B. A. Kernoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. B. A. Kernoff","raw_affiliation_strings":["The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Katharine Dormandy Haemophilia Centre, Royal Free Hospital and School of Medicine, London","institution_ids":["https://openalex.org/I2801138448"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5029562668"],"corresponding_institution_ids":["https://openalex.org/I2801138448"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":2.7516,"has_fulltext":false,"cited_by_count":172,"citation_normalized_percentile":{"value":0.89795918,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"52","issue":"2","first_page":"259","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viii-concentrate","display_name":"factor VIII concentrate","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.8489999771118164},{"id":"https://openalex.org/keywords/von-willebrand-disease","display_name":"von Willebrand disease","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cryoprecipitate","display_name":"cryoprecipitate","score":0.7720000147819519},{"id":"https://openalex.org/keywords/ion-exchange-chromatography","display_name":"ion-exchange chromatography","score":0.8790000081062317},{"id":"https://openalex.org/keywords/factor-viii-coagulant-activity","display_name":"factor VIII coagulant activity","score":0.8510000109672546},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.7120000123977661},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2778258694","wikidata":"https://www.wikidata.org/wiki/Q1923157","display_name":"Cryoprecipitate","level":3,"score":0.8991843461990356},{"id":"https://openalex.org/C2778385053","wikidata":"https://www.wikidata.org/wiki/Q134003","display_name":"Haemophilia","level":2,"score":0.7346062064170837},{"id":"https://openalex.org/C2777232031","wikidata":"https://www.wikidata.org/wiki/Q2092064","display_name":"Haemophilia A","level":3,"score":0.7002924680709839},{"id":"https://openalex.org/C2781221834","wikidata":"https://www.wikidata.org/wiki/Q425360","display_name":"Factor IX","level":2,"score":0.5129424929618835},{"id":"https://openalex.org/C2777081929","wikidata":"https://www.wikidata.org/wiki/Q2562598","display_name":"Haemophilia B","level":4,"score":0.5032729506492615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4784376919269562},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47539031505584717},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4672759771347046},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.4628964960575104},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4509704113006592},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44380828738212585},{"id":"https://openalex.org/C2779394231","wikidata":"https://www.wikidata.org/wiki/Q412310","display_name":"Von Willebrand factor","level":3,"score":0.4368566572666168},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4320615231990814},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3220694065093994},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.11750379204750061}],"mesh":[{"descriptor_ui":"D000941","descriptor_name":"Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005169","descriptor_name":"Factor VIII","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014841","descriptor_name":"von Willebrand Factor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014842","descriptor_name":"von Willebrand Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.1982.tb03888.x","doi":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1982.tb03888.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:6812613","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6812613","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W61388440","https://openalex.org/W1963589051","https://openalex.org/W1987448858","https://openalex.org/W1993684769","https://openalex.org/W1994619966","https://openalex.org/W2024970865","https://openalex.org/W2036129290","https://openalex.org/W2054374866","https://openalex.org/W2059197944","https://openalex.org/W2069546481","https://openalex.org/W2073354255","https://openalex.org/W2108868109","https://openalex.org/W2127368949","https://openalex.org/W2158841112","https://openalex.org/W2257693468","https://openalex.org/W2319306274","https://openalex.org/W2334932407","https://openalex.org/W2409187837","https://openalex.org/W2411116665","https://openalex.org/W2433258611","https://openalex.org/W4237530292"],"related_works":["https://openalex.org/W2884122316","https://openalex.org/W2024970865","https://openalex.org/W2884534705","https://openalex.org/W2884310312","https://openalex.org/W275965681","https://openalex.org/W2413894884","https://openalex.org/W2019129633","https://openalex.org/W1980930778","https://openalex.org/W2033247230","https://openalex.org/W2399310475"],"abstract_inverted_index":{"Factor":[0],"VIII":[1,44,107,129,156],"was":[2,18,112,118,133,149],"purified":[3,20],"from":[4],"cryoprecipitate":[5],"by":[6],"ion":[7],"exchange":[8],"chromatography":[9],"on":[10],"solid":[11],"phase":[12],"polyelectrolyte":[13],"E-5":[14],"(PE-E5).":[15],"The":[16,99,125],"product":[17],"highly":[19],"(3.5":[21],"u":[22,30],"VIII:C/mg":[23,31],"protein)":[24,32],"compared":[25],"to":[26,48,65,135],"conventional":[27],"concentrate":[28,90],"(0.3":[29],"with":[33,68,75,188],"low":[34,36],"fibrinogen,":[35],"isoagglutinin":[37],"titre,":[38],"and":[39,72,115,146],"a":[40,121,173,196],"ratio":[41],"of":[42,54,58,87,103,127,137,144,147,154,177,198,202],"factor":[43,49,128,203],"coagulant":[45,130],"activity":[46],"(VIII:C)":[47],"VII":[50],"related":[51],"antigen":[52,131],"(VIIIR:Ag)":[53],"16:1.":[55],"Trial":[56],"infusions":[57,86],"this":[59,170],"material":[60],"(PE":[61],"VIII)":[62],"were":[63,95,185],"given":[64],"three":[66],"patients":[67,81],"severe":[69,183],"haemophilia":[70],"A":[71],"one":[73],"patient":[74,159,171],"homozygous":[76],"von":[77,161],"Willebrand's":[78,162],"disease.":[79],"These":[80],"also":[82],"each":[83],"received":[84],"separate":[85],"intermediate":[88],"purity":[89],"(IPC)":[91],"for":[92],"comparison.":[93],"There":[94],"no":[96],"adverse":[97],"effects.":[98],"mean":[100],"half":[101,142],"life":[102,143],"VIII:C":[104,145],"after":[105,116,152],"PE":[106,155,189],"infusion":[108,153],"in":[109,157,169,182],"the":[110,141,158],"haemophiliacs":[111,184],"10.9":[113],"h":[114],"IPC":[117,166],"12.1":[119],"h,":[120],"statistically":[122],"insignificant":[123],"difference.":[124],"survival":[126],"(VIII:CAg)":[132],"similar":[134],"that":[136],"VIII:C.":[138,178],"In":[139],"contrast,":[140],"VIII:CAg":[148],"very":[150],"short":[151],"wih":[160],"disease":[163],"(2.4":[164],"h).":[165],"when":[167],"infused":[168],"produced":[172],"typical":[174],"secondary":[175],"rise":[176],"Two":[179],"bleeding":[180],"episodes":[181],"satisfactorily":[186],"treated":[187],"VIII.":[190,204],"PE-E5":[191],"deserves":[192],"further":[193],"study":[194],"as":[195],"means":[197],"preparing":[199],"clinical":[200],"concentrates":[201]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
